Investigations on the anti-inflammatory and anti-allergic activities of the leaves of Uncaria guianensis (Aublet) J. F. Gmelin

Inflammopharmacology. 2006 Mar;14(1-2):48-56. doi: 10.1007/s10787-006-1509-5.

Abstract

Uncaria guianensis (Aublet) J. F. Gmelin is an herbal medicine from tropical areas of South and Central America. We investigated the anti-inflammatory and anti-allergic properties of an ethanolic extract of U. guianensis leaves, containing alkaloids, flavonoids and phenol carboxylic acids, as revealed by thin layer chromatography (TLC). Oral pre-treatment with U. guianensis inhibited zymosan-induced paw oedema (500 mg/paw) and pleural exudation (100 mg/kg) within 4 h (25-200 mg/kg). U. guianensis (100 mg/kg) inhibited total leukocyte and neutrophil numbers in the pleural cavity 4 h after zymosan stimulation. Pre-treatment with U. guianensis (100 mg/kg, p.o.) inhibited total leukocyte, neutrophil and eosinophil recruitment into the pleural cavity 24 h after LPS (250 ng/cavity, i.t.). Pre-treatment with U. guianensis inhibited paw oedema (25-200 mg/kg) induced by ovalbumin (OVA) within 1 h, and neutrophil and eosinophil recruitment into the mice pleural cavity 24 h after OVA (100 mg/kg). In vitro data revealed that U. guianensis impaired LPS-induced nitric oxide and CXCL8 generation by murine peritoneal macrophages, as well as OVA-induced interleukin-5 synthesis by previously sensitized spleen cells. These results demonstrate that U. guianensis leaves provide effective anti-inflammatory and anti-allergic activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Allergic Agents / administration & dosage
  • Anti-Allergic Agents / pharmacology
  • Anti-Allergic Agents / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Chemokine CXCL1
  • Chemokines, CXC / metabolism
  • Chemotaxis, Leukocyte / drug effects
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Edema / drug therapy*
  • Edema / immunology
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide / metabolism
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Plant Leaves / chemistry
  • Pleurisy / drug therapy*
  • Pleurisy / immunology
  • Tumor Necrosis Factor-alpha / metabolism
  • Uncaria / chemistry*
  • Zymosan

Substances

  • Anti-Allergic Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Chemokine CXCL1
  • Chemokines, CXC
  • Cxcl1 protein, mouse
  • Intercellular Signaling Peptides and Proteins
  • Plant Extracts
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Zymosan